I remember when some thought it would be crazy to think a successful Reduce It outcome trial would result in the PPS reaching double digits.
I figure we're going to be in the 30's with more supporting data, approved label expansion (perhaps super duper expansion), resolved patent litigation and EU partnership so $35-40 seems woefully low for a Buyout.
Then again I figure JL will take us all out to the woodshed if BO discussions continue.